266 related articles for article (PubMed ID: 22623952)
41. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
42. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma.
Yin H; Wang X; Zhang X; Wang Y; Zeng Y; Xiong Y; Li T; Lin R; Zhou Q; Ling H; Zhou F; Zhou Y
Cancer Sci; 2018 Oct; 109(10):3336-3349. PubMed ID: 30152187
[TBL] [Abstract][Full Text] [Related]
43. Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis.
Petrozza V; Costantini M; Tito C; Giammusso LM; Sorrentino V; Cacciotti J; Porta N; Iaiza A; Pastore AL; Di Carlo A; Simone G; Carbone A; Gallucci M; Fazi F
Cancer Biomark; 2020; 27(2):181-188. PubMed ID: 31771042
[TBL] [Abstract][Full Text] [Related]
44. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
Nakata W; Uemura M; Sato M; Fujita K; Jingushi K; Ueda Y; Kitae K; Tsujikawa K; Nonomura N
Oncotarget; 2015 Aug; 6(25):21645-54. PubMed ID: 26046464
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent.
Gilyazova I; Ivanova E; Izmailov A; Sharifgaliev I; Karunas A; Pudova E; Kobelyatskaya A; Gilyazova G; Izmailova A; Pavlov V; Khusnutdinova E
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108073
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
48. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.
Bobowicz M; Skrzypski M; Czapiewski P; Marczyk M; Maciejewska A; Jankowski M; Szulgo-Paczkowska A; Zegarski W; Pawłowski R; Polańska J; Biernat W; Jaśkiewicz J; Jassem J
Clin Exp Metastasis; 2016 Dec; 33(8):765-773. PubMed ID: 27485175
[TBL] [Abstract][Full Text] [Related]
49. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
50. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma.
Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R; Slaby O
J Transl Med; 2012 Mar; 10():55. PubMed ID: 22440013
[TBL] [Abstract][Full Text] [Related]
51. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.
Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J
Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399
[TBL] [Abstract][Full Text] [Related]
52. A Novel miRNA-Based Model Can Predict the Prognosis of Clear Cell Renal Cell Carcinoma.
Wu J; Zhang F; Zhang J; Sun Z; Hao C; Cao H; Wang W
Technol Cancer Res Treat; 2021; 20():15330338211027923. PubMed ID: 34159861
[TBL] [Abstract][Full Text] [Related]
53. Identification and validation of a four-miRNA (miRNA-21-5p, miRNA-9-5p, miR-149-5p, and miRNA-30b-5p) prognosis signature in clear cell renal cell carcinoma.
Xie M; Lv Y; Liu Z; Zhang J; Liang C; Liao X; Liang R; Lin Y; Li Y
Cancer Manag Res; 2018; 10():5759-5766. PubMed ID: 30532596
[TBL] [Abstract][Full Text] [Related]
54. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.
Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH
Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153
[TBL] [Abstract][Full Text] [Related]
55. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.
Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O
Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176
[TBL] [Abstract][Full Text] [Related]
56. [Correlation between serum level of miRNA-106a expression with clinicopathological characteristics and prognosis of patients with renal cell carcinoma].
Yang Q; Liu J; Liang Y; Wang C; Han J; Zhu L; Yuan S; Sun Q; Zhang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jul; 38(7):652-655. PubMed ID: 34247370
[TBL] [Abstract][Full Text] [Related]
57. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
[TBL] [Abstract][Full Text] [Related]
58. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
[TBL] [Abstract][Full Text] [Related]
59. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
[TBL] [Abstract][Full Text] [Related]
60. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]